| Eye-q Vision Care | |
|
7075 N Sharon Ave, Fresno, CA 93720-3329 | |
| (559) 486-2000 | |
| Not Available |
| Full Name | Eye-q Vision Care |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 7075 N Sharon Ave, Fresno, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023283413 | NPI | - | NPPES |
| GSD001070 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| 207W00000X | Ophthalmology | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Eye-q Vision Care 7075 N Sharon Ave, Fresno, CA 93720-3329 Ph: (559) 486-2000 | Eye-q Vision Care 7075 N Sharon Ave, Fresno, CA 93720-3329 Ph: (559) 486-2000 |
News Archive
In the United States today, healthcare providers seem appropriately confused about present and future issues concerning coronavirus disease 2019 (COVID-19).
A new study in today's issue of the Journal of Bone and Joint Surgery found minimal risk for severe infection with osseointegrated implants-a newer prosthetic system, press-fitted directly into the femur bone-that enables bone growth over a metal, robotic prosthetic limb in patients with above knee amputations.
British researchers have discovered a new way of detecting which breast cancer patients are going to respond best to chemotherapy that includes anthracycline antibiotics. The study has found that an abnormality on chromosome 17, called CEP17, is not only associated with a worse outcome for patients, but also that its presence is a highly significant indicator that the tumour will respond to anthracyclines. The research will be presented at the European Breast Cancer Conference (EBCC7) Thursday 25th March.
A meta-analysis of previously published cancer research showed no difference in five-year and 10-year survival rates between patients who underwent radical cystectomy, which is the surgical removal of the bladder, and a bladder-preserving combined modality treatment (CMT) plan, which combines radiation therapy, chemotherapy and the removal of the bladder tumor.
› Verified 8 days ago
Dr. Scott Randall Hultman, O,D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3636 N Blackstone Ave, Fresno, CA 93726 Phone: 559-244-3319 | |
Dr. Thomas Pearson, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1360 E Herndon Ave, Suite 401, Fresno, CA 93720 Phone: 559-449-5010 Fax: 559-449-5014 | |
Dr. Andrea Cristina Huerta, OD Optometrist Medicare: Medicare Enrolled Practice Location: 7075 N Sharon Ave, Fresno, CA 93720 Phone: 559-389-5723 Fax: 559-256-8595 | |
Dr. David R Urien, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5430 N Palm Ave, Suite 101, Fresno, CA 93704 Phone: 559-432-0606 Fax: 559-432-0608 | |
Dr. Steven W. Shute, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 7075 N Sharon Ave, Fresno, CA 93720 Phone: 559-486-2000 | |
Dr. Elmer Wong, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6700 N 1st St, 103, Fresno, CA 93710 Phone: 559-438-6440 Fax: 559-438-4324 |